nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation
|
Song, Yang |
|
2017 |
23 |
6 |
p. 906-912 |
artikel |
2 |
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma
|
Mark, Tomer M. |
|
2017 |
23 |
6 |
p. 930-937 |
artikel |
3 |
ASBMT News
|
|
|
2017 |
23 |
6 |
p. 1041 |
artikel |
4 |
Citrulline and Monocyte-Derived Macrophage Reactivity before Conditioning Predict Acute Graft-versus-Host Disease
|
Hueso, Thomas |
|
2017 |
23 |
6 |
p. 913-921 |
artikel |
5 |
Commentary: Role of Mesenchymal Stromal Cell–Mediated Crosstalk with Macrophages in Graft-versus-Host Disease and Tissue Repair
|
Davies, Lindsay C. |
|
2017 |
23 |
6 |
p. 861-862 |
artikel |
6 |
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study
|
Richardson, Paul G. |
|
2017 |
23 |
6 |
p. 997-1004 |
artikel |
7 |
Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program
|
Miyamoto, Toshihiro |
|
2017 |
23 |
6 |
p. 938-944 |
artikel |
8 |
Do Patients and Physicians Agree When They Assess Quality of Life?
|
Barata, Anna |
|
2017 |
23 |
6 |
p. 1005-1010 |
artikel |
9 |
Editorial Board
|
|
|
2017 |
23 |
6 |
p. A5 |
artikel |
10 |
Erratum to: Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation [Biol Blood Marrow Transplant 2017;23:333-339]
|
Patriarca, Francesca |
|
2017 |
23 |
6 |
p. 1040 |
artikel |
11 |
Evaluation of the Pharmacokinetics and Efficacy of a Busulfan Test Dose in Adult Patients Undergoing Myeloablative Hematopoietic Cell Transplantation
|
Weil, Elizabeth |
|
2017 |
23 |
6 |
p. 952-957 |
artikel |
12 |
Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide
|
Shah, Nirali N. |
|
2017 |
23 |
6 |
p. 980-990 |
artikel |
13 |
Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation
|
Preussler, Jaime M. |
|
2017 |
23 |
6 |
p. 1021-1028 |
artikel |
14 |
Hematopoietic Stem Cell Transplant for a New Primary Immunodeficiency Disorder: A Voyage Where No Transplant Physician Has Gone Before
|
Connelly, James A. |
|
2017 |
23 |
6 |
p. 863-864 |
artikel |
15 |
Human Mesenchymal Stem Cell–Educated Macrophages Are a Distinct High IL-6–Producing Subset that Confer Protection in Graft-versus-Host-Disease and Radiation Injury Models
|
Bouchlaka, Myriam N. |
|
2017 |
23 |
6 |
p. 897-905 |
artikel |
16 |
Infection Followed by Graft-versus-Host Disease: Pathogenic Role of Antibiotics
|
Rashidi, Armin |
|
2017 |
23 |
6 |
p. 1038-1039 |
artikel |
17 |
Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes
|
Madbouly, Abeer |
|
2017 |
23 |
6 |
p. 1029-1037 |
artikel |
18 |
Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience
|
Michelis, Fotios V. |
|
2017 |
23 |
6 |
p. 945-951 |
artikel |
19 |
Masthead (Purpose and Scope)
|
|
|
2017 |
23 |
6 |
p. A4 |
artikel |
20 |
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report
|
Gea-Banacloche, Juan |
|
2017 |
23 |
6 |
p. 870-881 |
artikel |
21 |
Officers and Directors of ASBMT
|
|
|
2017 |
23 |
6 |
p. A6 |
artikel |
22 |
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies
|
Barker, Juliet N. |
|
2017 |
23 |
6 |
p. 882-896 |
artikel |
23 |
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes
|
Gerds, Aaron T. |
|
2017 |
23 |
6 |
p. 971-979 |
artikel |
24 |
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology
|
Krishnan, Amrita Y. |
|
2017 |
23 |
6 |
p. 922-929 |
artikel |
25 |
Prognostic Index for Critically Ill Allogeneic Transplantation Patients
|
Bayraktar, Ulas D. |
|
2017 |
23 |
6 |
p. 991-996 |
artikel |
26 |
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection
|
Kosuri, Satyajit |
|
2017 |
23 |
6 |
p. 965-970 |
artikel |
27 |
Retrospective Analysis of 37,287 Observation Years after Peripheral Blood Stem Cell Donation
|
Schmidt, Alexander H. |
|
2017 |
23 |
6 |
p. 1011-1020 |
artikel |
28 |
Table of Contents
|
|
|
2017 |
23 |
6 |
p. A11-A18 |
artikel |
29 |
The Impact of Splenectomy in Myelofibrosis Patients before Allogeneic Hematopoietic Stem Cell Transplantation
|
Robin, Marie |
|
2017 |
23 |
6 |
p. 958-964 |
artikel |
30 |
Uncertainty of Physicians and Patients in Medical Decision Making
|
Dhawale, Tejaswini |
|
2017 |
23 |
6 |
p. 865-869 |
artikel |